Tempest Therapeutics, Inc. Stock Split Ratio
Tempest Therapeutics, Inc. (TPST) reported Stock Split Ratio of 202.30% for the 0-month period ending 2012-03-29, per its 10-K filed 2015-03-16.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2015-03-16
- 2012-03-29: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 202.30%.
- 2012-03-28: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 202.30%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month |
|---|---|
| 2012-03-29 | 202.30% 10-K · filed 2015-03-16 |
| 2012-03-28 | 202.30% 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |